C. Aurrecoechea, J. Brestelli, B. P. Brunk, J. Dommer, S. Fischer et al., PlasmoDB: a functional genomic database for malaria parasites, Nucleic Acids Research, vol.37, issue.Database, pp.37-539, 2009.
DOI : 10.1093/nar/gkn814
URL : http://doi.org/10.1093/nar/gkn814

A. Azzi, C. Cosseau, and C. Grunau, Schistosoma mansoni: Developmental arrest of miracidia treated with histone deacetylase inhibitors, Experimental Parasitology, vol.121, issue.3, pp.288-291, 2009.
DOI : 10.1016/j.exppara.2008.11.010
URL : https://hal.archives-ouvertes.fr/halsde-00371695

J. L. Banks, H. S. Beard, Y. Cao, A. E. Cho, W. Damm et al., Integrated Modeling Program, Applied Chemical Theory (IMPACT), Journal of Computational Chemistry, vol.24, issue.16, pp.1752-1780, 2005.
DOI : 10.1002/jcc.20292
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742605

M. Berg, R. Garcia-hernandez, B. Cuypers, M. Vanaerschot, J. I. Manzano et al., Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations, Antimicrobial Agents and Chemotherapy, vol.59, issue.4, pp.2242-2255, 2015.
DOI : 10.1128/AAC.04231-14
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356759

P. Bose, Y. Dai, and S. Grant, Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights, Pharmacology & Therapeutics, vol.143, issue.3, pp.323-336, 2014.
DOI : 10.1016/j.pharmthera.2014.04.004

G. L. Brien, D. G. Valerio, and S. A. Armstrong, Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs, Cancer Cell, vol.29, issue.4, pp.464-476, 2016.
DOI : 10.1016/j.ccell.2016.03.007

B. K. Chaal, A. P. Gupta, B. D. Wastuwidyaningtyas, Y. H. Luah, and Z. Bozdech, Histone Deacetylases Play a Major Role in the Transcriptional Regulation of the Plasmodium falciparum Life Cycle, PLoS Pathogens, vol.13, issue.1, p.1000737, 2010.
DOI : 10.1371/journal.ppat.1000737.s004

K. Cheeseman and J. B. Weitzman, Host-parasite interactions: an intimate epigenetic relationship, Cellular Microbiology, vol.5, issue.Suppl., pp.1121-1132, 2015.
DOI : 10.1111/cmi.12471

S. Clive, M. M. Woo, T. Nydam, L. Kelly, M. Squier et al., Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients, Cancer Chemotherapy and Pharmacology, vol.68, issue.4, pp.513-522, 2012.
DOI : 10.1007/s00280-012-1940-9

B. I. Coleman, K. M. Skillman, R. H. Jiang, L. M. Childs, L. M. Altenhofen et al., A Plasmodium falciparum Histone Deacetylase Regulates Antigenic Variation and Gametocyte Conversion, Cell Host & Microbe, vol.16, issue.2, pp.177-186, 2014.
DOI : 10.1016/j.chom.2014.06.014
URL : http://doi.org/10.1016/j.chom.2014.06.014

D. G. Colley, A. L. Bustinduy, W. E. Secor, and C. H. King, Human schistosomiasis, The Lancet, vol.383, issue.9936, pp.2253-2264, 2014.
DOI : 10.1016/S0140-6736(13)61949-2

S. L. Croft, S. Sundar, and A. H. Fairlamb, Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-126, 2006.
DOI : 10.1128/CMR.19.1.111-126.2006

S. J. Darkin-rattray, A. M. Gurnett, R. W. Myers, P. M. Dulski, T. M. Crumley et al., Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase, Proc. Natl. Acad. Sci. U. S. A. 93, pp.13143-13147, 1996.
DOI : 10.1073/pnas.93.23.13143
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24060

A. M. Dondorp, F. Nosten, P. Yi, D. Das, A. P. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009.
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794

A. M. Dondorp and P. Ringwald, Artemisinin resistance is a clear and present danger, Trends in Parasitology, vol.29, issue.8, pp.359-360, 2013.
DOI : 10.1016/j.pt.2013.05.005

G. S. Dow, Y. Chen, K. T. Andrews, D. Caridha, L. Gerena et al., Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.52, issue.10, pp.3467-3477, 2008.
DOI : 10.1128/AAC.00439-08

F. Dubois, S. Caby, F. Oger, C. Cosseau, M. Capron et al., Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni, Molecular and Biochemical Parasitology, vol.168, issue.1, pp.7-15, 2009.
DOI : 10.1016/j.molbiopara.2009.06.001
URL : https://hal.archives-ouvertes.fr/halsde-00459184

E. Durieu, E. Prina, O. Leclercq, N. Oumata, N. Gaboriaud-kolar et al., From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity, Antimicrobial Agents and Chemotherapy, vol.60, issue.5, pp.2822-2833, 2016.
DOI : 10.1128/AAC.00021-16
URL : https://hal.archives-ouvertes.fr/hal-01299756

J. A. Engel, A. J. Jones, V. M. Avery, S. D. Sumanadasa, S. S. Ng et al., Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites, International Journal for Parasitology: Drugs and Drug Resistance, vol.5, issue.3, pp.117-126, 2015.
DOI : 10.1016/j.ijpddr.2015.05.004

A. European-medicines, Assessment Report: Farydak (Procedure No, 2015.

K. J. Falkenberg and R. W. Johnstone, Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders, Nature Reviews Drug Discovery, vol.405, issue.9, pp.673-691, 2014.
DOI : 10.1523/JNEUROSCI.0096-06.2006

L. H. Freitas-junior, R. Hernandez-rivas, S. A. Ralph, D. Montiel-condado, O. K. Ruvalcaba-salazar et al., Telomeric Heterochromatin Propagation and Histone Acetylation Control Mutually Exclusive Expression of Antigenic Variation Genes in Malaria Parasites, Cell, vol.121, issue.1, pp.25-36, 2005.
DOI : 10.1016/j.cell.2005.01.037

R. Furumai, A. Matsuyama, N. Kobashi, K. H. Lee, M. Nishiyama et al., (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases, Cancer Res, vol.62, issue.17, pp.228-4916, 2002.

K. P. Garnock-jones, Panobinostat: First Global Approval, Drugs, vol.28, issue.3, pp.695-704, 2015.
DOI : 10.1007/s40265-015-0388-8

S. Grant, C. Easley, and P. Kirkpatrick, Vorinostat, Nature Reviews Drug Discovery, vol.102, issue.1, pp.21-22, 2007.
DOI : 10.1038/nrd2227

C. Gruring, R. W. Moon, C. Lim, A. A. Holder, M. J. Blackman et al., parasites: a new model system for malaria research, Cellular Microbiology, vol.923, issue.5, pp.612-620, 2014.
DOI : 10.1111/cmi.12275

T. Heimburg, A. Chakrabarti, J. Lancelot, M. Marek, J. Melesina et al., for the Treatment of Schistosomiasis, Journal of Medicinal Chemistry, vol.59, issue.6, pp.2423-2435, 2016.
DOI : 10.1021/acs.jmedchem.5b01478

N. D. Heintzman, G. C. Hon, R. D. Hawkins, P. Kheradpour, A. Stark et al., Histone modifications at human enhancers reflect global cell-type-specific gene expression, Nature, vol.17, issue.7243, pp.108-112, 2009.
DOI : 10.1038/nature07829
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910248

W. Huber and J. C. Koella, A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites, Acta Tropica, vol.55, issue.4, pp.257-261, 1993.
DOI : 10.1016/0001-706X(93)90083-N

S. M. Kavanaugh, L. A. White, and J. M. Kolesar, Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma: Figure 1, American Journal of Health-System Pharmacy, vol.67, issue.10, pp.67-793, 2010.
DOI : 10.2146/ajhp090247

F. Kiefer, K. Arnold, M. Kunzli, L. Bordoli, and T. Schwede, The SWISS-MODEL Repository and associated resources, Nucleic Acids Research, vol.37, issue.Database, pp.387-392, 2009.
DOI : 10.1093/nar/gkn750
URL : http://doi.org/10.1093/nar/gkn750

C. Lim, E. Hansen, T. M. Desimone, Y. Moreno, K. Junker et al., Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans, Nature Communications, vol.110, 1638.
DOI : 10.1038/ncomms2612

R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya et al., Global and regional mortality from 235 causes of death for 20 age groups, Z.J. Lancet, vol.380, issue.9859, 1990.
URL : https://hal.archives-ouvertes.fr/hal-00827612

M. Marek, S. Kannan, A. T. Hauser, M. Mourao, M. Caby et al., Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni, Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni, p.1003645, 2013.
DOI : 10.1371/journal.ppat.1003645.s007

M. Marek, G. Oliveira, R. J. Pierce, M. Jung, W. Sippl et al., Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives, Future Medicinal Chemistry, vol.7, issue.6, pp.783-800, 2015.
DOI : 10.4155/fmc.15.25

J. Marfurt, F. Chalfein, P. Prayoga, F. Wabiser, E. Kenangalem et al., Ex Vivo Activity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates of Plasmodium falciparum and P. vivax, Antimicrobial Agents and Chemotherapy, vol.55, issue.3, pp.961-966, 2011.
DOI : 10.1128/AAC.01220-10

M. Marxer, K. Ingram, and J. Keiser, Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula, Parasites & Vectors, vol.5, issue.1, p.165, 2012.
DOI : 10.1017/S0031182009990552

J. Melesina, D. Robaa, R. J. Pierce, C. Romier, and W. Sippl, Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors, Journal of Molecular Graphics and Modelling, vol.62, pp.342-361, 2015.
DOI : 10.1016/j.jmgm.2015.10.006

J. Miao, Q. Fan, L. Cui, and J. Li, The malaria parasite Plasmodium falciparum histones: Organization, expression, and acetylation, Gene, vol.369, pp.53-65, 2006.
DOI : 10.1016/j.gene.2005.10.022

M. F. Montenegro, L. Sanchez-del-campo, M. P. Fernandez-perez, M. Saez-ayala, J. Cabezas-herrera et al., Targeting the epigenetic machinery of cancer cells, Oncogene, vol.139, issue.112, pp.135-143, 2015.
DOI : 10.1038/onc.2013.605

R. W. Moon, J. Hall, F. Rangkuti, Y. S. Ho, N. Almond et al., Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes, Proceedings of the National Academy of Sciences, vol.110, issue.2, pp.531-536, 2013.
DOI : 10.1073/pnas.1216457110

C. J. Murray, T. Vos, R. Lozano, M. Naghavi, A. D. Flaxman et al., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990???2010: a systematic analysis for the Global Burden of Disease Study 2010, Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, pp.2197-2223, 1990.
DOI : 10.1016/S0140-6736(12)61689-4
URL : https://hal.archives-ouvertes.fr/hal-00827610

G. Panic, D. Flores, K. Ingram-sieber, and J. Keiser, Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays, Parasites & Vectors, vol.11, issue.Suppl(May), p.624, 2015.
DOI : 10.1186/s13071-015-1233-3

V. Patel, R. Mazitschek, B. Coleman, C. Nguyen, S. Urgaonkar et al., Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum, J. Med. Chem, issue.8, pp.52-2185, 2009.

V. Patil, W. Guerrant, P. C. Chen, B. Gryder, D. B. Benicewicz et al., Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group, Bioorganic & Medicinal Chemistry, vol.18, issue.1, pp.415-425, 2010.
DOI : 10.1016/j.bmc.2009.10.042

P. Pescher, T. Blisnick, P. Bastin, and G. F. Spath, Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cellular Microbiology, vol.48, issue.7, pp.978-991, 2011.
DOI : 10.1111/j.1462-5822.2011.01593.x
URL : https://hal.archives-ouvertes.fr/pasteur-01433560

H. M. Prince, M. J. Bishton, and R. W. Johnstone, Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors, Future Oncology, vol.5, issue.5, pp.601-612, 2009.
DOI : 10.2217/fon.09.36

H. M. Prince and M. Dickinson, Romidepsin for Cutaneous T-cell Lymphoma, Clinical Cancer Research, vol.18, issue.13, pp.3509-3515, 2012.
DOI : 10.1158/1078-0432.CCR-11-3144

A. Saul, N. Prescott, F. Smith, Q. Cheng, and D. Walliker, Evidence of cross-contamination among laboratory lines of Plasmodium berghei1Note: Nucleotide sequence data reported in this paper have been submitted to the Genbank??? data base with accession numbers U65085???65088.1, Molecular and Biochemical Parasitology, vol.84, issue.1, pp.143-147, 1997.
DOI : 10.1016/S0166-6851(96)02779-X

T. S. Skinner-adams, K. T. Andrews, L. Melville, J. Mccarthy, and D. L. Gardiner, Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In Vitro, Antimicrobial Agents and Chemotherapy, vol.51, issue.2, pp.759-762, 2007.
DOI : 10.1128/AAC.00840-06

S. D. Sumanadasa, C. D. Goodman, A. J. Lucke, T. Skinner-adams, I. Sahama et al., Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3849-3856, 2012.
DOI : 10.1128/AAC.00030-12

S. Sundar and J. Chakravarty, An update on pharmacotherapy for leishmaniasis, Expert Opinion on Pharmacotherapy, vol.4, issue.3, pp.237-252, 2015.
DOI : 10.1086/655134
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293334

S. Takala-harrison, C. G. Jacob, C. Arze, M. P. Cummings, J. C. Silva et al., Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia, Journal of Infectious Diseases, vol.211, issue.5, pp.670-679, 2015.
DOI : 10.1093/infdis/jiu491

C. A. Thompson, Belinostat approved for use in treating rare lymphoma, American Journal of Health-System Pharmacy, vol.71, issue.16, pp.71-1328, 2014.
DOI : 10.2146/news140056

C. J. Tonkin, C. K. Carret, M. T. Duraisingh, T. S. Voss, S. A. Ralph et al., Sir2 Paralogues Cooperate to Regulate Virulence Genes and Antigenic Variation in Plasmodium falciparum, PLoS Biology, vol.431, issue.4, p.84, 2009.
DOI : 10.1371/journal.pbio.1000084.sd001

W. Trager and J. B. Jensen, Human malaria parasites in continuous culture, Science, vol.193, issue.4254, pp.673-675, 1976.
DOI : 10.1126/science.781840

K. Trenholme, L. Marek, S. Duffy, G. Pradel, G. Fisher et al., Lysine Acetylation in Sexual Stage Malaria Parasites Is a Target for Antimalarial Small Molecules, Antimicrobial Agents and Chemotherapy, vol.58, issue.7, pp.3666-3678, 2014.
DOI : 10.1128/AAC.02721-13

M. Vanderstraete, N. Gouignard, K. Cailliau, M. Morel, J. Lancelot et al., Dual Targeting of Insulin and Venus Kinase Receptors of Schistosoma mansoni for Novel Anti-schistosome Therapy, PLoS Neglected Tropical Diseases, vol.63, issue.1, p.2226, 2013.
DOI : 10.1371/journal.pntd.0002226.g008

N. C. Wheatley, K. T. Andrews, T. L. Tran, A. J. Lucke, R. C. Reid et al., Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.23, pp.7080-7084, 2010.
DOI : 10.1016/j.bmcl.2010.09.096

P. Yeo, L. Xin, E. Goh, L. S. New, P. Zeng et al., Development and validation of high-performance liquid chromatography???tandem mass spectrometry assay for 6-(3-benzoyl-ureido)-hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies, Biomedical Chromatography, vol.6, issue.2, pp.184-189, 2007.
DOI : 10.1002/bmc.734

J. Zhang and Q. Zhong, Histone deacetylase inhibitors and cell death, Cellular and Molecular Life Sciences, vol.18, issue.Suppl 2, pp.3885-3901, 2014.
DOI : 10.1007/s00018-014-1656-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414051